FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Housekeeper expected to play key role in trial of wife accused of husband’s murder in wealthy ski town

Secret tapes sink shooter’s defense in Scott Spivey road rage killing

Angel Families praise Trump for immigration crackdown: ‘You are the man’

Trump halts Angel Families speech to check on woman in audience

Watch: CNN Host Goes Rogue on Air, Saying ‘Blue Cities Are Out of Control’ and Then Tearing Them Apart for 2 Minutes Straight

Watch: Media Melts Down After Kash Celebrates Team USA Win with a Chest Thump and Beer in His Hand – But He’s Not Backing Down

Kim Jong Un reelected as North Korean leader, teen daughter to serve as ‘missile chief’

Trump fires judge-picked US attorney as top DOJ official warns courts to stay in their lane

Reporter’s Notebook: Trump’s State of the Union becomes political boxing match as Democrats boycott

First antifa terrorism trial restarts following mistrial: What you need to know

Newsom’s office rebuffs ‘MAGA-manufactured outrage’ on his SAT score statement

Judge permanently blocks release of Trump classified documents report

JPMorgan Makes Humiliating Admission in Trump’s $5 Billion Debanking Lawsuit

WATCH: ‘I Can Send a Military Plane or Something’ – Trump Called the US Men’s Hockey Team After Their Historic Win and Made an Offer They Couldn’t Refuse

Trump says Supreme Court ruling against birthright citizenship order would benefit China

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”